# Atorvastatin in Pulmonary Hypertension

> **NCT00615823** · PHASE2 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 220 (actual)

## Conditions studied

- Hypertension, Pulmonary

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00615823
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2010-03
- **Final completion:** 2010-05
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2012-02-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00615823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00615823, "Atorvastatin in Pulmonary Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00615823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*